Arterial hypertension and obstructive sleep apnoea;Arterielle Hypertonie und obstruktive Schlafapnoe

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 14, 1997, Pages 455-459

  Sturm, A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HYPERTENSION; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SLEEP APNEA SYNDROME;

EID: 0030887521     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1237399     Document Type: Review

References (54)

1. Blumberg, H., J. Oberle: Effects of sytemic hypoxia and hypercapnia on skin and muscle sympathetic acitivity in humans. Pflügers Arch. 403 (1985), 51 (Abstract).
2. Boudoulas, H., H. Schmidt, P. Gelens, R. W. Clark, R. P. Lewis: Case reports on deterioration of sleep apnea during therapy with propranolol. Res. Commun. chem. Pathol. Pharm. 39 (1983), 3-10.
3. Burmann-Urbanek, M., J. Wiemann, B. Sanner, I. Kreuzer: Internistische Erkrankungen im Schlaf. In Rasche, K., M. Konermann et al. (Hrsg.): Schlafbezogene Atmungsstörungen (MMV-Medizinverlag: München 1994), 107-108.
4. Carlson, J., R. Davies, K. Ehlenz, R. Grunstein: Obstructive sleep apnea and blood pressure elevation. Blood Pressure 2 (1993), 166.
5. Carlson, J., J. Hedner, H. Ejnell, L. Peterson: High prevalence of hypertension in sleep apnea patients independent of obesity. Amer. J. Crit. Care Med. 150(1994), 72-77.
6. Clark, R. W.: Propanolol and the treatment of sleep attacks. Ann. intern. Med. 92 (1980), 718-719.
7. Classen, M., V. Diehl, K. Kochsiek (Hrsg.): Innere Medizin, 3. Auflage (Urban und Schwarzenberg: Baltimore 1994).
8. Davies, R. O., J. Crosby, A. Prothero et al.: Ambulatory blood pressure and left ventricular hypertrophy in subjects with untreated obstructive sleep apnoea and snoring. Clin. Sci. 86 (1994), 417.
9. Dzau, V. J., G. H. Gibbons, R. E. Pratt: Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension 18 (Suppl. 2) (1991), 100-105.
10. Ehlenz, K.: Regulation of blood volume-implications for cardiovascular pathophysiology in sleep apnea. J. Sleep Res. 4 (Suppl. 1) (1995), 30-33.
11. Ehlenz, K., P. Herzog, P. von Wiehert, H. Kaffarnik, J. H. Peter: Renal excretion of endothelin in obstructive sleep apnea syndrome. In Gaultier, Escourrou, Curzi-Dascalova (Hrsg.): Sleep and cardiorespiratory control. Colloque Inserm. 217 (1991), 226.
12. Ehlenz, K., J. H. Peter: Volumenregulation und Hochdruckgenese beim obstruktiven Schlaf-Apnoe-Syndrom. In Peter, J. H., T. Penzel, W. Casse, P. von Wiehert (Hrsg.): Schlaf - Atmung - Kreislauf (Springer: Berlin 1993), 258.
13. Ehlenz, K., J. H. Peter, H. Kaffarnik, P. v. Wiehert: Disturbances in volume regulating hormone system. Pneumologie 45 (1991), 239.
14. Ehlenz, K., J. H. Peter, H. Schneider, T. Elle, H. Kaffarnik, P. v. Wichert: Changes in volume regulating hormones during treatment of obstructive sleep apnea. Sleep Res. 20 (1991), 94.
15. Fletcher, E. C.: The relationship between systemic hypertension and obstructive sleep apnea. Amer. J. Med. 98 (1995), 118-128.
16. Fletcher, E. C., J. Miller, J. W. Schaaf, J. G. Fletcher: Urinary catecholamines before and after tracheostomy in OSA and hypertension. Sleep 10 (1987), 35-44.
17. Findley, L., M. Boykin, T. Fallo, L. Belardinelli: Plasma adenosine and hypoxemia in patients with sleep apnea. J. appl. Physiol. 64 (1988), 556-561.
18. Folkow, B.: Psychosocial and central nervous influences in primary hypertension. Circulation 76 (Suppl. 1) (1987), 10-19.
19. Garpestad, E., J. Ringler, J. A. Parker, S. Remsburg, J. W. Weiss: Sleep stage influences the hemodynamic response to obstructive apneas. Amer. J. Respir. Crit. Care Med. 152 (1995), 199-203.
20. Grote, L.: Schlaf - Atmung - Hämodynamik. Internist 37 (1996), 470-482.
21. Grote, L., J. Heitmann, H. Schneider, T. Ploch, T. Penzel, J. H. Peter, P. v. Wiehert: Twenty-Four-Hour blood pressure control. J. Cardiovasc. Pharm. 24 (Suppl. 3) (1994), 78.
22. Guilleminault, C., F. B. Simmons, J. Motta: Obstructive sleep apnea syndrome and tracheostomy. Arch. intern. Med. 141 (1981), 987.
23. Guilleminault, C., M. Suzuki: Sleep-related hemodynamics and hypertension with partial or complete upper airway obstruction during sleep. Sleep 15 (1992), 20-24.
24. Guilleminault, C., R. Stoohs, A. Clerk: From obstructive sleep apnea syndrome to upper airway resistance syndrome. Sleep 15(1992), 13.
25. He, J. H., M. H. Kryger, F. J. Zorick, W. Conway, T. Roth: Mortality and apnea index in obstructive sleep apnea. Chest 94 (1988), 9-14.
26. Hedner, J.: Daytime waking autonomic function and vascular control in OSA. J. Sleep Res. 4 (Suppl. 1) (1995), 171-175.
27. Hedner, J., H. Ejnell, J. Sellgren et al.: High muscle nerve sympathetic activity in the sleep apnea syndrome. J. Hypert. 6 (1988), 529-531.
28. Hedner, J. A., I. Wilcox, L. Laks: A specific and potent pressor effect of hypoxia in patients with sleep apnea. Amer. Rev. Respir. Dis. 146 (1992), 1240-1245.
29. Hla, K. M., T. B. Young; T. Bidwell et al.: Sleep apnea and hypertension. Ann. intern. Med. 120 (1994), 382-388.
30. Hoffstein, V., C. K. Chan, A. S. Slutsky: Sleep Apnoe and systemic hypertension. Amer. J. of Medicine 91 (1991), 190-196.
31. Horio, T., M. Kohno, K. Yokokawa: Effects of hypoxia on plasma immunoreactive endothelin-I concentration in anesthetized rats. Metabolism 40 (1991), 999-1001.
32. Isaksson, H., E. Svanborg: Obstructive sleep apnea syndrome in male hypertensives, refractory to drug therapy. Clin. Exp. Hypertens (A) 13 (1991), 1195-1212.
33. Jennum, P., G. Wildschiodtz, N. J. Christensen, T. Schwartz: Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal continuous positive airway pressure (nCPAP) treatment. Amer. J. Hypertens. 2 (1989), 847.
34. Konermann, M., B. Sanner, J. Kiewer, I. Kreuzer, F. Laschewski, M. Burmann-Urbanek: Entwicklung kardiopulmonaler Leistungsparameter bei Patienten mit obstruktiver Schlafapnoe unter nCPAP-Therapie. Wien. Klin. Wschr. 146 (1996), 340-342.
35. Leuenberger, U. A., E. M. Jakob, L. W. Sweer et al.: Hypoxemia and surges of sympathetic activity mediate blood pressure oscillations in obstructive sleep apnea. Circulation 86 (Suppl. 1) (1992), 631.
36. Lusher, T. F., C. M. Boulanger, Y. Dohi, Z. Yang: Endothelium-derived contracting factors. Hypertension 19 (1992), 117-130.
37. Mayer, J., H. Becker, U.. Brandenburg: Blood pressure and sleep apnea. Cardiology 79 (1991), 84-92.
38. Mayer, J., U. Weichler, B. Herres-Mayer et al.: Influence of Metoprolol and Cilaprizil on blood pressure and on sleep apnea activity. J. Cardiovasc. Pharmacol. 16 (1990), 952-961.
39. Nicholson, A. M.: Effects on sleep and wakefullness. In Kryger, M. H., T. Rott, W. C. Dement (Hrsg.): Principles and practice of sleep medicine (Saunders: Philadelphia 1989), 228.
40. peter, J. H., U. Bolm-Audorff, E. Becker et al.: Schlafapnoe und essentielle Hypertonie. Verh. Dtsch. Ges. Inn. Med. 89 (1983), 1132.
41. Peter, J. H., W. Gassei, J. Mayer: Effects of cilazapril on hypertension, sleep, and apnea. Amer. J. Med. 87 (6 B) (1989), 72-78.
42. Pohl, U., R. Busse: Hypoxia stimulates release of endothelium-derived relaxant factor. Amer. J. Physiol. 256 (1989), 1595-1601.
43. Sanner, B., A. Sturm, M. Konermann: Koronare Herzerkrankung bei Patienten mit obstruktiver Schlafapnoe. Dtsch. med. Wschr. 121 (1996), 931-935.
44. Schäfer, H., U. Höhler, E. Hasper, S. Ewig, B. Lüderitz: Schlafapnoe und cardiovasculäres Risiko. Z. Kardiol. 84 (1995), 871-884.
45. Shepard, J. W. jr.: Gas exchange and hemodynamics during sleep. Med. Clin. N. Amer. (69 (1985), 1243-1246.
46. Snyder, F., J. A. Hobson, F. M. Morrison, F. Goldfrank: Changes in respiration, heart rate and systolic blood pressure in human sleep. J. appl. Physiol. 19 (1964), 417-422.
47. Sturm, A.: Gibt es ein charakteristisches Schlaf-Apnoe-Cor? Dtsch. med. Wschr. 119 (1984), 531-534.
48. Sturm, A., P. Clarenbach. Schlafstörungen: Checklisten der Aktuellen Medizin (Thieme: Stuttgart 1997).
49. Sturm, A., H. Pfleiderer: Alkohol und arterielle Hypertonie. Dtsch. med. Wschr. 111 (1986), 1787-1789.
50. Suzuki, M., K. Otsuka, C. Guilleminault: Longterm nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 16 (1993), 545.
51. Tafil-Klawe, M., J. Klawe, R. Moog et al.: Arterielle Baro- und Chemorezeptorenreflexe bei Schlafapnoe-Patienten. In Peter, J. H., T. Penzel, W. Cassel, P. v. Wiehert (Hrsg.): Schlaf - Atmung - Kreislauf (Springer: Berlin 1993), 142-163.
52. Trzebski, A.: Arterial chemoreceptor reflex and hypertension. Hypertension 19 (1992), 562-566.
53. Vane, J. R., E. E. Änggard, R. M. Botting: Regulatory functions of the vascular endothelium. New Engl. J. Med. 323 (1990), 27-36.
54. Wilcox, I., R. R. Grunstein, J. A. Hedner: Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnoa. Sleep 16 (1993), 539-544.